CNS Drugs

Potential New Methods for Antiepileptic Drug Delivery
pp. 579-593(15)
Authors: Fisher R.S.; Ho J.

Clinical Implications of CNS Penetration of Antiretroviral Drugs
pp. 595-609(15)
Authors: Wynn H.E.; Brundage R.C.; Fletcher C.V.

New and Emerging Prophylactic Agents for Migraine
pp. 611-634(24)
Authors: Krymchantowski A.V.; Bigal M.E.; Moreira P.F.

Nefazodone in the Treatment of Elderly Patients with Depressive Disorders: A Prospective, Observational Study
pp. 635-643(9)
Authors: Saiz-Ruiz J.; Ibañez A.; Díaz-Marsá M.; Arias F.; Carrasco J.L.; Huertas D.; Martín-Carrasco M.; Moreno I.; Rico-Villademoros F.

Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder
pp. 645-652(8)
Authors: Gunasekara N.S.; Spencer C.M.; Keating G.M.